# FDA Inspection 1195333 - LXR Biotech - January 20, 2023

Source: https://www.keypedia.com/records/fda_inspections/lxr-biotech/89adf9b7-fbd9-495f-9e44-68b8b21a4a37
Source feed: FDA_Inspections

> FDA Inspection 1195333 for LXR Biotech on January 20, 2023. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195333
- Company Name: LXR Biotech
- Inspection Date: 2023-01-20
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1321344 - 2026-06-10](https://www.keypedia.com/records/fda_inspections/lxr-biotech/48900175-c5de-43a4-a264-44897c421ba6)
- [FDA Inspection 1321344 - 2026-06-10](https://www.keypedia.com/records/fda_inspections/lxr-biotech/b90954fd-cc85-4ef3-b3a0-df598568c29c)
- [FDA Inspection 1263581 - 2025-03-12](https://www.keypedia.com/records/fda_inspections/lxr-biotech/ba6284fd-f55e-48d5-b5e8-251931cf5389)
- [FDA Inspection 1263581 - 2025-03-12](https://www.keypedia.com/records/fda_inspections/lxr-biotech/055f99c3-44f1-4b2a-9dfc-d5974cddf1df)
- [FDA Inspection 1229957 - 2024-02-16](https://www.keypedia.com/records/fda_inspections/lxr-biotech/80012072-0127-40ff-a46b-2e35c2285cc7)

Company: https://www.keypedia.com/companies/lxr-biotech/eb654be9-a1c6-4c8d-95da-a470fc37bba9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c